C-Encode Logo

FRAX, narrative ยท Westview Imaging Centre, MRN SMP-100236, DOB 1954-01-01

Bone Mineral Density

Height(cm): 161.2
Weight(kg): 48.4
BONE MINERAL DENSITY DATA:
Compared with previous examination on 2024-03-04.
LUMBAR SPINE (L1-L4) = 0.936 g/cm2. T-score = -2.0. Z-score = -0.4. This value has DECREASED by 0.010 g/cm2 (-1.1%) compared to the previous. LEFT FEMORAL NECK = 0.670 g/cm2. T-score = -2.6. Z-score = -1.0. LEFT TOTAL PROXIMAL FEMUR = 0.717 g/cm2. T-score = -2.3. Z-score = -0.9. This value has DECREASED by 0.047 g/cm2 (-6.2%) compared to the previous.

DIAGNOSTIC CATEGORY: Osteoporosis.

10-YEAR MAJOR OSTEOPOROTIC FRACTURE RISK (FRAX): 11.5%

RISK FACTORS: None.

BONE-ACTIVE DRUG THERAPY: No.

LIMITATIONS: Fracture risk is likely underestimated because an osteoporotic T-score at the lumbar spine, femoral neck, or total hip is not accounted for in FRAX.

INTERVAL CHANGE:
Lumbar Spine: No significant interval change. Left Total Proximal Femur: Significant interval decrease.

RECOMMENDATIONS: Pharmacotherapy is suggested as per the 2023 Osteoporosis Canada guideline. Consider a thoracic and/or lumbar spine x-ray to assess for possible compression fractures. Finding of undiagnosed vertebral fracture(s) can guide appropriate choice and duration of therapy.

FOLLOW-UP: 1 year, given significant interval bone loss.

For definitions, follow-up timelines, scanner specifics, and other reference information, visit the Westview Imaging Centre physician resources page. This report follows the CAR Practice Guideline on Bone Mineral Densitometry Reporting: 2024 Update and the Osteoporosis Canada 2023 Clinical Practice Guideline for Management of Osteoporosis and Fracture Prevention in Canada.

Sample output for illustration. Patient details are fictional; the report layout and wording are produced by DXA Encode.